Premium
Transcatheter valve‐in‐valve for failing bioprosthetic aortic valve: Usually a good idea
Author(s) -
Khan Asaad,
Dangas George
Publication year - 2018
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.28003
Subject(s) - medicine , aortic valve , aortic valve replacement , cardiology , valve replacement , heart valve , surgery , stenosis
Key Points Use of bioprosthetic implants for surgical aortic valve replacements (SAVR) has been increasing in the recent years Surgical redo AVRs for failed surgical aortic bioprostheses have been traditionally considered the standard practice; however, in patients with higher surgical risk scores, transcatheter valve‐in‐valve aortic valve replacements are being commonly performed There is scarcity of data comparing these two approaches in this complex patient cohort Available data suggest that transcatheter ViV aortic valve replacement is generally a safe approach once some caveats are accounted for